[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-340828-105":59,"doc-detail-340828-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","identification-of-hub-genes-distinguishing-subtypes-in-endometrial-stromal-sarcoma-through-comprehensive-bioinformatics-analysis","Identification of hub genes distinguishing subtypes in endometrial stromal sarcoma through comprehensive bioinformatics analysis","","Diagnosing low-grade and high-grade endometrial stromal sarcoma remains difficult, and reliable differential biomarkers are limited. This study analyzed 22 ESS cases using Illumina microarrays and identified differentially expressed genes with Limma, followed by STRING/Cytoscape network analysis and GO/KEGG functional enrichment. Exome sequencing and external GSE85383 data yielded shared genes and 10 core candidates, including RBFOX1, PCDH7, and FAT1. Pan-cancer evaluation highlighted immune-related DEGs such as IGF1 and AVPR1A, supporting biomarker potential and therapeutic target discovery.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/identification-of-hub-genes-distinguishing-subtypes-in-endometrial-stromal-sarcoma-through-comprehensive-bioinformatics-analysis/340828/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/identification-of-hub-genes-distinguishing-subtypes-in-endometrial-stromal-sarcoma-through-comprehensive-bioinformatics-analysis/340828.png","ImageObject",300,407,{"name":92,"@type":93},"Jiven","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":19},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main goal of this study on endometrial stromal sarcoma?","Question",{"text":112,"@type":113},"To identify biomarkers and hub genes that distinguish low-grade endometrial stromal sarcoma (LG-ESS) from high-grade (HG-ESS).","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were differentially expressed genes (DEGs) identified?",{"text":117,"@type":113},"DEGs were detected using Limma from Illumina microarray data, with thresholds based on logFC and adjusted p-values, and DEGs were further supported using GEO dataset GSE85383.",{"name":119,"@type":110,"acceptedAnswer":120},"Which core genes were selected as potential hub candidates?",{"text":121,"@type":113},"Ten core genes were selected, including RBFOX1, PCDH7, and FAT1, based on common and core gene intersection analyses.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},340828,1791079375,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":19,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099513958607,"https://ap-avatar.wpscdn.com/avatar/100002390cf8733938c?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778829742770036399","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nIdentification of hub genes distinguishing subtypes in endometrial stromal sarcoma through comprehensive bioinformatics analysis  \nRuiqi Zhang1,4, Weilin Zhao3,4, Xingyao Zhu2, Yuhua Liu1, Qi Ding1, Caiyun Yang1 & Hong Zou2*  \nDiagnosing low-grade and high-grade endometrial stromal sarcoma (LG-ESS and HG-ESS) is a challenge. This study aimed to identify biomarkers. 22 ESS cases were analyzed using Illumina microarrays. Differentially expressed genes (DEGs) were identified via Limma. DEGs were analyzed with String and Cytoscape. Core genes were enriched with GO and KEGG, their pan-cancer implications and immune aspects were studied. 413 DEGs were found by exome sequencing, 2174 by GSE85383 microarray. 36 common genes were identified by Venn analysis, and 10 core genes including RBFOX1, PCDH7, FAT1 were selected. Core gene GO enrichment included cell adhesion, T cell proliferation, and KEGG focused on related pathways. Expression was evaluated across 34 cancers, identifying immune DEGs IGF1 and AVPR1A. Identifying the DEGs not only helps improve our understanding of LG-ESS, HG-ESS but also promises to be potential biomarkers for differential diagnosis between LG-ESS and HG-ESS and new therapeutic targets.  \nAbbreviations  \nESS Endometrial stromal sarcoma  \nLG-ESS Low-grade endometrial stromal sarcoma HG-ESS High-grade endometrial stromal sarcoma DEGs Differentially expressed genes  \nPPI Protein–protein interaction network  \nGO Gene ontology  \nKEGG Kyoto encyclopedia of genes and genomes BP Biological process  \nCC Cellular component  \nMF Molecular function  \nSNP Single nucleotide polymorphism GEO Gene expression omnibus TIMER Tumor immune estimation resource  \nIHC Immunohistochemistry  \nEndometrial stromal sarcoma (ESS), an infrequent mesometrial-origin tumor, exhibits marked malignancy levels1,2. The latest World Health Organization classification divides ESS into low-grade (LG-ESS) and highgrade (HG-ESS) categories based on severity1. Clinical studies underscore distinct treatment approaches and prognoses for these types, yet biomarkers for their differential diagnosis remain scarce. This study endeavors to identify potential biomarkers for distinguishing between HG-ESS and LG-ESS.  \n1Department of Pathology, The First Affiliated Hospital, Shihezi University School of Medicine, Xinjiang 832002, China. 2Department of Pathology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Zhejiang 310009, China. 3Department of Pathology, Taihe Hospital, Hubei University of Medicine, Hubei 442000, China. 4These authors contributed equally: Ruiqi Zhang and Weilin Zhao. *[email: zouhong@zju.edu.cn](email: zouhong@zju.edu.cn)  \n[www. nature.com/scientificreports/](www. nature.com/scientificreports/)  \nWhile the past decade’s research methods for ESS have centered on molecular fusion gene markers crucial to diagnosis3–6, current literature predominantly comprises retrospective case reports. Studies, confined to immunohistochemistry and fusion genes, offer limited insights into genetic commonalities and disparities between LG-ESS and HG-ESS subtypes. Recent genomic innovations present opportunities to grasp comprehensive tumor tissue biology. Genome-wide single nucleotide polymorphism (SNP) analysis, assessing genomes and transcripts in small sample sets, can identify target genes effectively7. SNPs offer extensive human genome loci coverage, ease of high-throughput typing, and cost-efficient sequencing, catering to the rarity ofESS.  \nIn this study, we employed exon microarray technology to sequence 22 wax block samples (15 LG-ESSand 7 HG-ESS cases) . Combining these with GEO platform data facilitated initial differential expression gene (DEG) screening between LG-ESS and HG-ESS groups. STRING platform (Search Tool for Interacting Genes Retrieval) (Version 12.0) and Cytoscape software (Software platform for visualizing molecular interaction ne","cbCair5TvNKue7Rf","https://ap.wps.com/l/cbCair5TvNKue7Rf","pdf",4788217,11,"English","# Abstract\n# Abbreviations\n# Introduction\n# Materials and methods\n## Patient and tissue specimens\n## DNA extraction and SNP array\n## Microarray data acquisition and standardization","[{\"question\":\"What is the main goal of this study on endometrial stromal sarcoma?\",\"answer\":\"To identify biomarkers and hub genes that distinguish low-grade endometrial stromal sarcoma (LG-ESS) from high-grade (HG-ESS).\"},{\"question\":\"How were differentially expressed genes (DEGs) identified?\",\"answer\":\"DEGs were detected using Limma from Illumina microarray data, with thresholds based on logFC and adjusted p-values, and DEGs were further supported using GEO dataset GSE85383.\"},{\"question\":\"Which core genes were selected as potential hub candidates?\",\"answer\":\"Ten core genes were selected, including RBFOX1, PCDH7, and FAT1, based on common and core gene intersection analyses.\"}]","Identification of hub genes distinguishing subtypes in endometrial stromal sarcoma through comprehensive bioinformatics analysis | PDF",1790039073,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d8ae8aa3bf33dcb284c4ad728a67a643.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5c2a168b95803383b2d4e0f597741b6a.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0df670147f8d27d0cc44f76ddf287dba.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/66f86befdf3d6afc974a9370d3e463ec.webp",980,1287]